Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 5, 2004, Pages 826-831

  Rendi Wagner, Pamela ^a   Georgopoulos, Apostolos ^a   Kundi, Michael ^a   Mutz, Ingomar ^b   Mattauch, Markus ^c   Nowak, Jacek ^c   Mikolasek, Andrea ^a   Vecsei, Andreas ^d   Kollaritsch, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Leoben Hospital   (Austria)

^c PFIZER INC   (United States)

^d ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Incidence; S.pneumoniae; Serotype coverage; Susceptibilities

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFPODOXIME; CEFTRIAXONE; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRIA; BACTERIAL MENINGITIS; CONTROLLED STUDY; FATALITY; FEMALE; GERMANY; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; AUSTRIA; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SEROTYPING;

EID: 2442705390     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh211     Document Type: Article

References (36)

1. Bluestone, C. D., Stephenson, J. S. & Martin, L. M. (1992). Ten-year review of otitis media pathogens. Pediatric Infectious Disease Journal 11, s7-s11.
2. Saarinen, M., Takala, A. K. & Koskenniemi, E. (1995). Spectrum of 2,836 cases of pediatric invasive infections: results of a prospective nationwide 5-year surveillance in Finland. Clinical Infectious Diseases 21, 1134-44.
3. Schuchat, A., Robinson, K., Wenger, J. D. et al. (1997). Bacterial meningitis in the United States in 1995. Active Surveillance Team. New England Journal of Medicine 337, 970-6.
4. Hausdorff, W. P. (2002). Invasive pneumococcal disease in children: geographic and temoral variations in incidence and serotype distribution. European Journal of Pediatrics 161, Suppl. 2, S135-9.
5. Davidson, M., Parkinson, A. J., Bulkow, L. R. et al. (1994). The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention. Journal of Infectious Diseases 170, 368-76.
6. Trotman, J., Hughes, B. & Mollison, L. (1995). Invasive pneumococcal disease in central Australia. Clinical Infectious Diseases 20, 1553-6.
7. Levine, M. M., Lagos, R., Levine, O. S. et al. (1998). Epdemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country. Pediatric Infectious Disease Journal 17, 287-93.
8. Appelbaum, P. C. (1996). Epidemiology and in-vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatric Infectious Disease Journal 15, 932-9.
9. Tomasz, A. (1997). Antibiotic resistance in Streptococcus pneumoniae. Clinical Infectious Diseases 24, Suppl. 1, 85-8.
10. Georgopoulos, A., Buxbaum, A., Straschil, U. et al. (1998). Austrian National Survey of Prevalence of Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae 1994-96. Scandinavian Journal of Infectious Diseases 30, 345-9.
11. Buxbaum, A., Straschil, U., Graninger, W. et al. (1999). Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. Journal of Antimicrobial Chemotherapy 43, Suppl. B, 13-18.
12. Jacobs, M. R., Flemingham, D., Appelbaum P. C. et al. (2003). The Alexander Project 1998-2000: susceptibilty of pathogens isolated from community-acquired respiratory tract infections to commonly used antimicrobial agents. Journal of Antimicrobial Chemotherapy 52, 229-46.
13. Munoz, R., Musser, J. M., Crain, M. et al. (1992). Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterisation by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clinical Infectious Diseases 15, 112-8.
14. Black, S., Shinefield, H., Fireman, B. et al. (2000). Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatric Infectious Disease Journal 19, 187-95.
15. Shinefield, H. & Black, S. (2000). Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatric Infectious Disease Journal 19, 394-7.
16. Eskola, J., Kilpi, T., Palmu, A. et al. (2001). Efficacy of a pneumococcal conjugate vaccine against acute otitis media. New England Journal of Medicine 344, 403-9.
17. Whitney, C. G., Farley, M. M., Hadler, J. et al. (2003). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New England Journal of Medicine 348, 1737-46.
18. Nachman, S., Kim, S., King, J. et al. (2003). Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics 112, 66-73.
19. Spratt, B. C. (2000). Prevention of penumococcal disease by vaccination: does serotype replacement matter? Lancet 356, 1210-11.
20. National Committee for Clinical Laboratory Standards. (2003). Performance Standards for Antimicrobial Suscepitibilty Testing. Supplement Tables, M100-S13/M7. NCCLS, Wayne, PA, USA.
21. National Committee for Clinical Laboratory Standards. (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A6. NCCLS, Wayne, PA, USA.
22. Statistik Austria, Population Statistics. [Online.] http://www.statistik.at/index.shtml (20 January 2004, date last accessed).
23. Eskola, J., Takal, A. K., Kela, E. et al. (1992). Epidemiology of invasive pneumococcal infections in children in Finland. Journal of the American Medical Association 268, 3323-7.
24. Dagan, R., Engelhard, D., Piccard, E. et al. (1992). Epidemiology of invasive childhood pneumococcal infections in Israel: The Israeli Pediatric Bacteraemia and Meningitis Group. Journal of the American Medical Association 272, 1006.
25. Von Kries, R., Siedler, A., Heinz, J. et al. (2000). Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clinical Infectious Diseases 31, 482-7.
26. Robinson, K. A., Baughman, W., Rothrock, G. et al. (2001). Epidemiology of invasive Streptococcus infections in the United States, 1995-1998. Journal of the American Medical Association 285, 1729-35.
27. Kaltoft, M. S., Zeuthen, N. & Konradsen, H. B. (2000). Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: a 19-year nationwide surveillance study. Acta Pædiatrica 435, Suppl., 3-10.
28. Zangwill, K. M., Vadheim, C. M., Vannier, A. M. et al. (1996). Epidemiology of invasive pneumococcal disease in Southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. Journal of Infectious Diseases 174, 752-9
29. Venetz, I., Schopfer, K., Muhlemann, K. et al. (1998). Paediatric, invasive pneumococcal disease in Switzerland, 1985-1994. International Journal of Epidemiology 27, 1101-4.
30. Dowell, S. D., Whitney, C. G., Wright, C. et al. (2003). Seasonal patterns of invasive pneumococcal disease. Emerging Infectious Diseases 9, 573-9.
31. Von Kries, R., Hermann, M., Hachmeister, A. et al (2002). Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatric Infectious Disease Journal 21, 1017-23.
32. Buxbaum, A., Forsthuber, S., Graninger, W. et al. (2003) Comparative activity of telithromycin against typical community-acquired respiratory pathogens. Journal of Antimicrobial Chemotherapy 52, 371-4.
33. Reinert, R. R., Lütticken, R., Bryskier, A. et al. (2003). Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrobial Agents and Chemotherapy 47, 489-93.
34. Der Pharmazeutische Markt Oesterreichs III (The Pharmaceutical Market Austria). (2003). IMS AG Cham, Switzerland.
35. Oostenbrink, R., Maas, M., Moons, K. G. et al. (2002). Sequelae after bacterial meningitis in childhood. Scandinavian Journal of Infectious Diseases 34, 379-82.
36. Baraff, L. J., Lee, S. I. & Schriger, D. L. (1993) Outcomes of bacterial meningitis in children: a meta-analysis. Pediatric Infectious Disease Journal 12, 389-94.